Higher Prevalence of PldA, a Pseudomonas aeruginosa Trans-Kingdom H2-Type VI Secretion System Effector, in Clinical Isolates Responsible for Acute Infections and in Multidrug Resistant Strains
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Higher Prevalence of PldA, a Pseudomonas aeruginosa Trans-Kingdom H2-Type VI Secretion System Effector, in Clinical Isolates Responsible for Acute Infections and in Multidrug Resistant Strains
Authors
Keywords
-
Journal
Frontiers in Microbiology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-10-29
DOI
10.3389/fmicb.2018.02578
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Presence of pldA and exoU in mucoid Pseudomonas aeruginosa associated with high risk of exacerbations in non-CF bronchiectasis patients
- (2018) Rong-Guang Luo et al. CLINICAL MICROBIOLOGY AND INFECTION
- Pore-forming activity of the Pseudomonas aeruginosa type III secretion system translocon alters the host epigenome
- (2018) Laurent Dortet et al. Nature Microbiology
- Type VI secretion and anti-host effectors
- (2016) Abderrahman Hachani et al. CURRENT OPINION IN MICROBIOLOGY
- Aim, Load, Fire: The Type VI Secretion System, a Bacterial Nanoweapon
- (2016) Francesca R. Cianfanelli et al. TRENDS IN MICROBIOLOGY
- Pseudomonas aeruginosainfection in cystic fibrosis: pathophysiological mechanisms and therapeutic approaches
- (2016) Helena Lund-Palau et al. Expert Review of Respiratory Medicine
- Pseudomonas aeruginosa: arsenal of resistance mechanisms, decades of changing resistance profiles, and future antimicrobial therapies
- (2015) Mohamed E El Zowalaty et al. Future Microbiology
- A Pseudomonas aeruginosa Type VI Secretion Phospholipase D Effector Targets Both Prokaryotic and Eukaryotic Cells
- (2014) Feng Jiang et al. Cell Host & Microbe
- Prevalence of Type III Secretion Protein Exoenzymes and Antimicrobial Susceptibility Patterns from Bloodstream Isolates of Patients withPseudomonas aeruginosaBacteremia
- (2014) K.W. Garey et al. JOURNAL OF CHEMOTHERAPY
- Risk of Developing Pneumonia Is Enhanced by the Combined Traits of Fluoroquinolone Resistance and Type III Secretion Virulence in Respiratory Isolates of Pseudomonas aeruginosa*
- (2013) Eva Sullivan et al. CRITICAL CARE MEDICINE
- Hospital-acquired pneumonia and ventilator-associated pneumonia
- (2013) François Barbier et al. CURRENT OPINION IN PULMONARY MEDICINE
- Structure and Function of the Type III Secretion System of Pseudomonas aeruginosa
- (2013) Marlies Galle et al. CURRENT PROTEIN & PEPTIDE SCIENCE
- Diverse type VI secretion phospholipases are functionally plastic antibacterial effectors
- (2013) Alistair B. Russell et al. NATURE
- Transcriptional Response of Mucoid Pseudomonas aeruginosa to Human Respiratory Mucus
- (2012) V. Cattoir et al. mBio
- Prevalence of virulence genes among bulgarian nosocomial and cystic fibrosis isolates of Pseudomonas aeruginosa
- (2010) Ivan Mitov et al. BRAZILIAN JOURNAL OF MICROBIOLOGY
- Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues
- (2010) V. Miriagou et al. CLINICAL MICROBIOLOGY AND INFECTION
- Intercontinental Dissemination of IMP-13-Producing Pseudomonas aeruginosa Belonging in Sequence Type 621
- (2010) G. Santella et al. JOURNAL OF CLINICAL MICROBIOLOGY
- The type III secretion system of Pseudomonas aeruginosa: infection by injection
- (2009) Alan R. Hauser NATURE REVIEWS MICROBIOLOGY
- Metallo beta lactamases inPseudomonas aeruginosaand Acinetobacter species
- (2008) Varsha Gupta EXPERT OPINION ON INVESTIGATIONAL DRUGS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now